The photograph on the hallway wall
It's somebody's seventieth and you're standing in the hallway with a paper plate, looking at the framed photo of the women in your family. Your grandmother, your mother, two aunts, you at the end.
Same build. All of you carrying it in the same place, the way a family carries a nose.
In the kitchen behind you the conversation is doing what it always does. Your uncle's stent, and how they caught it in time. Whether your cousin's blood pressure tablets are the ones that make you cough. Your grandmother's sugar — never diabetes, always her sugar, the way it's always been said, like weather. Somebody mentions the aunt who spent two days certain it was indigestion, and the room goes quiet for a second, and then it doesn't.
And standing there in the hallway, what you are actually thinking about is whether this top was a mistake.
That's the part I want to sit with. Not the family history. The fact that you were standing inside a live conversation about arteries and blood sugar, looking at four women built exactly like you, and the thought in your head was about how you looked in a photograph.
You've had fifteen years of thinking about your middle as a thing to be disciplined, hidden, or apologised for. A tailoring problem. A summer problem. A before the wedding problem.
Nobody ever sat you down and said it might be the same sentence half that kitchen was already serving.
What you were actually looking at
Your waistband is not a mirror problem.
I mean that precisely, not as encouragement. Where your body stores fat is one of the more informative things about you, and it is information about your blood vessels, not your appearance. You have been reading it as a verdict on your self-control when it was closer to a lab result you never got told about.
And a lab result is the opposite of a life sentence, which is the other half of this. Of everything on the family's list that night — the stent, the tablets, the sugar — the thing driving most of it is also the single most responsive part of the whole system. That is not a pep talk. It's the rest of this post.
The same illness wearing different names
I wrote separately about why the fat goes to your middle rather than your arms and legs — high insulin, androgens rising, fat routed to the organs rather than under the skin. Start there for the how. This is the part that comes after.
Here's the thing that reorganised my thinking. Insulin resistance travels through families in its own right. Sisters of women with PCOS who don't have PCOS themselves — no irregular cycles, nothing to diagnose — still show reduced insulin sensitivity compared with unrelated women. It's in the relatives before there's anything to point at.
So look at that kitchen again. The same underlying problem was in most of those people. It just wore a different name in each of them depending on who they were and what got noticed. In your uncle it announced itself as chest pain and became a stent. In your grandmother it was called her sugar. In your aunt it was two days of what she thought was indigestion. In a woman of reproductive age, the name it wears is PCOS.
That isn't a metaphor. In a meta-analysis of over a million women, PCOS was associated with roughly two and a half times the odds of a heart attack, about 1.7 times the odds of stroke, and about 1.7 times the odds of cardiovascular disease overall. I'll be straight with you about the edge of that evidence: the link to cardiovascular death was not clear in the same analysis. The events are well established; the mortality picture is messier.
Which is why the 2023 international guideline says every woman with PCOS should have her heart risk factors assessed regardless of her BMI, and her blood sugar checked at diagnosis and then every one to three years.
Read that "regardless of BMI" part twice if you're slim. Among women who are not overweight, those with PCOS still show higher insulin resistance than those without — the risk is not something you earn by being a certain size, and thin women get skipped over precisely because everyone including their doctor is looking at the wrong variable.
Why your thirties matter more than your sixties
Here is where I have to be careful, because the version of this argument that would be most persuasive is one I can't support.
Nobody has randomised a group of twenty-five-year-olds with PCOS to metformin and followed them to sixty counting heart attacks. That trial doesn't exist. Anyone who tells you the drug will prevent your uncle's stent is going further than the evidence goes.
What does exist is this. In people with blood sugar already creeping up, the big prevention trial found that metformin cut progression to type 2 diabetes by about 31 percent over three years, and an intensive lifestyle programme cut it by about 58 percent — and both were still showing reduced diabetes more than twenty years later. That study wasn't done in women with PCOS, and the people in it were older and heavier than you probably are, so it's a bridge, not a proof.
But look at what the bridge connects. Insulin resistance is the thing driving the risk. It responds to treatment. Diabetes is a major route to the heart disease in your family, and delaying or preventing it is not a small intervention.
The honest summary: treating this at thirty-two is a bet on your fifties, and the evidence for that bet is strong on the middle steps and thinner at the two ends. Waiting is also a bet, and it's the one where the years accumulate quietly while nobody measures anything.
What to ask for
Ask for numbers, and bring the family with you. A HbA1c — a blood test showing your average blood sugar over about three months — or better, a glucose tolerance test, which the guideline names first choice. A lipid panel. Blood pressure. And say the family history out loud at the appointment: who has diabetes, who has had a heart attack or a stent, and at what age. That last detail changes how a clinician reads everything else.
Metformin lowers the sugar your liver puts out and improves how your tissues answer insulin. The international guideline recommends it for the metabolic side of PCOS. It's off-label here — approved for type 2 diabetes, used in PCOS on guideline recommendation rather than an FDA indication, which is ordinary rather than alarming. The real costs: stomach upset, worst early and worst on the standard form, usually better on the slow-release version, and B12 worth checking if you're on it for years.
GLP-1 medications improve insulin sensitivity and reliably reduce weight, with clear metabolic benefit. The PCOS-specific evidence for the reproductive side stays thin. Real trade-offs: nausea and constipation, insurance fights, muscle loss without enough protein and resistance training, and regain for many people who stop. They aren't for use in pregnancy and need a washout before trying to conceive.
The sentence:
There's type 2 diabetes and heart disease on both sides of my family, and I have PCOS. I'd like my HbA1c or a glucose tolerance test, a lipid panel and my blood pressure looked at now, and to talk about whether metformin makes sense at my age rather than later.
Two doors, and then it's yours
First door: your GP, OB-GYN, or endocrinologist. Bring the family history written down. Ask for the numbers in writing.
One reason to know your own risk rather than trusting the system to catch it: when women do have heart attacks, they are 50 percent more likely than men to be given the wrong initial diagnosis, according to a study of more than half a million patients — and a wrong initial diagnosis carried a 70 percent higher risk of death within thirty days. Your aunt's two days of indigestion was not an unusual story. If an appointment about any of this goes badly, that is information about the clinician, not about whether your risk is real.
Second door: telehealth built for this. Allara Health is a virtual practice for PCOS and women's hormonal and metabolic health that pairs clinicians with dietitians and works with many major insurance plans, though availability varies by state. Sesame is a direct-pay marketplace where you book a named clinician at a listed price without insurance or a referral.
I want to be clear that I have no financial relationship with either of these. I'm not an affiliate and I don't get paid if you book. I mention them because "find a doctor who actually knows PCOS" is useless advice without somewhere to start.
PCOS is managed, not cured, and no drug makes a family history disappear. But a heritable pattern is not the same as a fixed outcome, and the part of it doing the damage is the part that answers to treatment. The women in that photograph were never offered this conversation at your age. You are standing in front of it at exactly the point where it counts most — which is the one advantage in the whole picture, and it's yours.
This is my experience and my reading of the research, not medical advice. Nothing here should replace a conversation with a clinician who knows your history.
Sources
- 2023 International Evidence-Based PCOS Guideline Update: meta-analysis on elevated clinical cardiovascular disease in PCOS — Journal of the American Heart Association, 2024
- Altered glucose disposition and insulin sensitivity in peri-pubertal first-degree relatives of women with PCOS — International Journal of Pediatric Endocrinology, 2012
- Adolescent "lean PCOS" is characterized by higher insulin resistance and adverse adipokine profile — Journal of Clinical Endocrinology & Metabolism, 2025
- Diabetes Prevention Program Outcomes Study: persistent reduction of type 2 diabetes over 22-year average follow-up — American Diabetes Association, 2025
- Women are 50 per cent more likely than men to be given an incorrect diagnosis following a heart attack — British Heart Foundation / University of Leeds, 2016
- Recommendations from the 2023 International Evidence-based Guideline for the Assessment and Management of PCOS — Teede et al., Journal of Clinical Endocrinology and Metabolism, 2023